Current Drug Targets - Cardiovascular & Hematological Disorders

A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774962112 ◽

2005 ◽

Vol 5 (6) ◽

pp. 489-501 ◽

Cited By ~ 16

Author(s):

R. Mason

Keyword(s):

Calcium Channel ◽

Calcium Channel Blocker ◽

Clinical Evidence ◽

Channel Blocker ◽

Combined Therapy

Download Full-text

Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774962103 ◽

2005 ◽

Vol 5 (6) ◽

pp. 527-532 ◽

Cited By ~ 19

Author(s):

A. Zalewski ◽

C. Macphee ◽

J. Nelson

Keyword(s):

Phospholipase A2 ◽

Therapeutic Target ◽

Potential Therapeutic Target

Download Full-text

Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774962013 ◽

2005 ◽

Vol 5 (6) ◽

pp. 431-432

Author(s):

Paul Schoenhagen ◽

Steven Nissen

Keyword(s):

Disease Progression ◽

Atherosclerotic Disease

Download Full-text

Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774962022 ◽

2005 ◽

Vol 5 (6) ◽

pp. 513-525 ◽

Cited By ~ 17

Author(s):

I. Gouni-Berthold ◽

W. Krone

Keyword(s):

Peroxisome Proliferator ◽

Peroxisome Proliferator Activated Receptor

Download Full-text

Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774962040 ◽

2005 ◽

Vol 5 (6) ◽

pp. 463-469 ◽

Cited By ~ 26

Author(s):

Akira Miyazaki ◽

Tomoko Kanome ◽

Takuya Watanabe

Keyword(s):

Coenzyme A ◽

Cholesterol Acyltransferase ◽

Acyl Coenzyme A

Download Full-text

Cholesterol Absorption Blockade with Ezetimibe

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774962086 ◽

2005 ◽

Vol 5 (6) ◽

pp. 455-462 ◽

Cited By ~ 21

Author(s):

Peter Toth ◽

Michael Davidson

Keyword(s):

Cholesterol Absorption

Download Full-text

ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774962004 ◽

2005 ◽

Vol 5 (6) ◽

pp. 471-479 ◽

Cited By ~ 9

Author(s):

Sanjay Kaul ◽

Prediman Shah

Keyword(s):

Atherosclerotic Plaque ◽

Plaque Progression

Download Full-text

Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774961997 ◽

2005 ◽

Vol 5 (6) ◽

pp. 481-488 ◽

Cited By ~ 4

Author(s):

W. Van der Steeg ◽

K. El-Harchaoui ◽

J. Kuivenhoven ◽

J. Kastelein

Keyword(s):

Cardiovascular Disease ◽

High Density Lipoprotein ◽

Cholesteryl Ester ◽

Cholesteryl Ester Transfer Protein ◽

High Density Lipoprotein Cholesterol ◽

Density Lipoprotein ◽

High Density ◽

Lipoprotein Cholesterol ◽

Protein Inhibition ◽

Transfer Protein

Download Full-text

Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774961988 ◽

2005 ◽

Vol 5 (6) ◽

pp. 533-540 ◽

Cited By ~ 16

Author(s):

Dennis Bruemmer ◽

Ronald Law

Keyword(s):

Cardiovascular Diseases ◽

Liver X Receptors ◽

Novel Targets ◽

X Receptors

Download Full-text

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

Current Drug Targets - Cardiovascular & Hematological Disorders ◽

10.2174/156800605774962077 ◽

2005 ◽

Vol 5 (6) ◽

pp. 441-453 ◽

Cited By ~ 33

Author(s):

R. Kleemann ◽

T. Kooistra

Keyword(s):

Dietary Cholesterol ◽

Hmg Coa Reductase ◽

Reductase Inhibitors ◽

Hmg Coa Reductase Inhibitors ◽

Coa Reductase

Download Full-text

Current Drug Targets - Cardiovascular & Hematological Disorders
Latest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Bentham Science

A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence

Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression

Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis

Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase

Cholesterol Absorption Blockade with Ezetimibe

ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression

Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?

Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

Export Citation Format

Current Drug Targets - Cardiovascular & Hematological DisordersLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Bentham Science

A Rationale for Combined Therapy with a Calcium Channel Blocker and a Statin: Evaluation of Basic and Clinical Evidence

Lipoprotein-associated Phospholipase A2: A Potential Therapeutic Target for Atherosclerosis

Editorial: Emerging Pharmacological Strategies for the Prevention of Atherosclerotic Disease Progression

Peroxisome Proliferator-Activated Receptor ?? (PPAR??) and Atherosclerosis

Inhibitors of Acyl-Coenzyme A: Cholesterol Acyltransferase

Cholesterol Absorption Blockade with Ezetimibe

ApoA-I Milano/phospholipid Complexes Emerging Pharmacological Strategies and Medications for the Prevention of Atherosclerotic Plaque Progression

Increasing High-Density Lipoprotein Cholesterol Through Cholesteryl Ester Transfer Protein Inhibition: A Next Step in the Fight Against Cardiovascular Disease?

Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases

HMG-CoA Reductase Inhibitors: Effects on Chronic Subacute Inflammation and Onset of Atherosclerosis Induced by Dietary Cholesterol

Current Drug Targets - Cardiovascular & Hematological Disorders
Latest Publications